Core C: Advanced Co-Culture Engineering and Single Cell Statistics of Gut Immunology
核心C:肠道免疫学的高级共培养工程和单细胞统计
基本信息
- 批准号:8855411
- 负责人:
- 金额:$ 26.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibodiesAntigen-Presenting CellsAntigensB-LymphocytesBehaviorBiochemicalBiocompatible MaterialsBioinformaticsBiological AssayBiological ModelsBloodCell CountCell CycleCell Differentiation processCell LineCellsCellular StructuresChemotaxisCoculture TechniquesCollaborationsCulture TechniquesCytometryDataData AnalysesDendritic CellsDevelopmentDevicesDiseaseDistalEngineeringEnteralEnvironmentEnzyme-Linked Immunosorbent AssayEpithelial CellsEpitheliumFoundationsGenerationsGoalsHelicobacter pyloriHumanImageImage CytometryImmuneImmunologic MonitoringImmunologyIndividualInfectionInterferonsIntestinesInvestigationIonsIsotopesLigandsM cellMHC Class II GenesMeasurementMethodsMicrofluidic MicrochipsMicrofluidicsModalityMonitorOrganoidsPathway interactionsPhenotypePhysiologicalPopulationPredispositionProductionRaji CellReagentResearchResearch PersonnelRotavirusSalmonellaSalmonella typhiStomachStructureSystemTNFSF11 geneTechnologyTimeTissue EngineeringTissuesWorkbasecell typechemokinecytokinedata integrationdesigngastrointestinal epitheliumin vivointercellular communicationmacrophagemigrationmonocytenoveloptical imagingpathogenresearch studyresponsesingle cell analysisstatisticstrafficking
项目摘要
PROJECT SUMMARY – CORE C
The ACCESS-GI (Advanced Co-culture Engineering and Single cell Statistics of Gut Immunology) Core
C will provide a range of cutting edge approaches to Stanford NAMSED investigators (Projects 1, 2 and
pilots) to analyze intestinal/gastric epithelial cells and their interactions with immune cells both with and
without infection. In association with the Organoid Core B, we will carry out development work towards the
generation of organoids that integrate mucosal immune cells. Specifically, in Aim 1, we will leverage highly
multiplexed, single cells analysis (CyTOF mass cytometry) and imaging (multiplexed ion beam imaging – MIBI)
modalities collaboratively developed at Stanford by Sean Bendall to provide cell analysis assays for projects
across the NAMSED center (Projects 1, 2). These assays will be uniquely beneficial, allowing the
simultaneous characterization of human gut organoid structure, the integration of immune cells, and the effects
of pathogens on cellular behavior. Further to this, Core C will facilitate access to other analysis modalities
available through Stanford's human immune monitoring core (HIMC), including 63-plex Luminex for
quantitative measurement of human cytokines and chemokines, standard ELISA for non-Luminex targets, and
Fluidigm Biomark for single cell qPCR analysis. The core will leverage the expertise of Sean Bendall, his team,
and the HIMC for analysis of data generated by these platforms and, where appropriate, for multi-platform data
integration. In Aim 2, Sarah Heilshorn and her team will provide novel assays to NAMSED investigators
(Projects 1, 2), using microfluidic devices that allow investigation of cell/cell and cell/pathogen interactions in
highly controlled micro-environments. In Aim 3, Elizabeth Mellins and her team, in collaboration with the
Organoid Core, will provide M-cell-like organoids to Project 1, and class II expressing organoids and develop
production of organoids with physiologic levels of M cells. Her team will also provide homogenous immune cell
populations to NAMSED investigators for experiments addressing immune reactivity in the context of infected
intestinal organoids (Project 1) as well as study interactions of selected antigen presenting cells with
uninfected and infected organoids. The latter will form the foundation of a key effort, in collaboration with the
Organoid Core, to develop human intestinal organoids that more closely replicate the physiologic
microenvironment encountered by pathogens during enteric infection.
项目摘要 - 核心C
访问GI(高级共文化工程和肠道免疫学的单细胞统计)核心
C将为斯坦福大学的调查员提供一系列最前沿的方法(项目1、2和
飞行员)分析肠/胃上皮细胞及其与免疫细胞与与免疫细胞的相互作用
没有感染。与类器官B相关,我们将进行开发工作
产生整合粘膜免疫细胞的器官。具体来说,在AIM 1中,我们将高度利用
多路复用的单细胞分析(质量细胞仪)和成像(多路复用离子束成像 - MIBI)
肖恩·本德尔(Sean Bendall)在斯坦福大学开发的方式为项目提供细胞分析分析
跨越名称中心(项目1、2)。这些评估将是独特的,允许
人肠癌结构的简单表征,免疫细胞的整合和影响
病原体对细胞行为的影响。除此之外,核心C将有助于访问其他分析方式
可通过斯坦福大学的人类免疫监测核心(HIMC)获得,其中包括63 plex luminex
人类细胞因子和趋化因子的定量测量,非luminex靶标的标准ELISA以及
流体化生物标志物用于单细胞QPCR分析。核心将利用他的团队Sean Bendall的专业知识
以及用于分析这些平台生成的数据以及适当的多平台数据的数据
在AIM 2中,Sarah Heilshorn和她的团队将为纳入调查人员提供新颖的测定
(项目1,2),使用允许研究细胞/细胞和细胞/病原体相互作用的微流体设备
高度控制的微环境。在AIM 3中,伊丽莎白·梅林斯(Elizabeth Mellins)和她的团队与
器官核心将为项目1提供类似M细胞的类器官,并表达II类并发展
具有M细胞生理水平的器官的产生。她的团队还将提供同质的免疫细胞
在被感染的情况下,向名称的研究者进行了针对免疫反应性的实验
肠癌(项目1)以及选择抗原呈现细胞与
未感染和感染的类器官。后者将与
器官核,开发人肠癌,更紧密地复制生理
肠道感染期间病原体遇到的微环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sean Curtis Bendall其他文献
Sean Curtis Bendall的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sean Curtis Bendall', 18)}}的其他基金
Uncoupling Age- Versus Cognitive-Related Cellular Senescence in Alzheimer's Disease
阿尔茨海默病中年龄与认知相关的细胞衰老的解耦
- 批准号:
10454751 - 财政年份:2020
- 资助金额:
$ 26.58万 - 项目类别:
Uncoupling Age- Versus Cognitive-Related Cellular Senescence in Alzheimer's Disease
阿尔茨海默病中年龄与认知相关的细胞衰老的解耦
- 批准号:
10043941 - 财政年份:2020
- 资助金额:
$ 26.58万 - 项目类别:
Uncoupling Age- Versus Cognitive-Related Cellular Senescence in Alzheimer's Disease
阿尔茨海默病中年龄与认知相关的细胞衰老的解耦
- 批准号:
10670998 - 财政年份:2020
- 资助金额:
$ 26.58万 - 项目类别:
Uncoupling Age- Versus Cognitive-Related Cellular Senescence in Alzheimer's Disease
阿尔茨海默病中年龄与认知相关的细胞衰老的解耦
- 批准号:
10222561 - 财政年份:2020
- 资助金额:
$ 26.58万 - 项目类别:
Stanford Cancer Immune Monitoring and Analysis Center (CIMAC)
斯坦福癌症免疫监测与分析中心 (CIMAC)
- 批准号:
10730465 - 财政年份:2017
- 资助金额:
$ 26.58万 - 项目类别:
Immune Monitoring and Analysis of Cancer at Stanford (IMACS)
斯坦福大学癌症免疫监测和分析 (IMACS)
- 批准号:
9456826 - 财政年份:2017
- 资助金额:
$ 26.58万 - 项目类别:
A single-cell platform to discover and study regulators of human development
发现和研究人类发育调节因子的单细胞平台
- 批准号:
8425506 - 财政年份:2013
- 资助金额:
$ 26.58万 - 项目类别:
A single-cell platform to discover and study regulators of human development
发现和研究人类发育调节因子的单细胞平台
- 批准号:
8840350 - 财政年份:2013
- 资助金额:
$ 26.58万 - 项目类别:
Core C: Advanced Co-Culture Engineering and Single Cell Statistics of Gut Immunology
核心C:肠道免疫学的高级共培养工程和单细胞统计
- 批准号:
9022402 - 财政年份:
- 资助金额:
$ 26.58万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
- 批准号:
10822182 - 财政年份:2023
- 资助金额:
$ 26.58万 - 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 26.58万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 26.58万 - 项目类别:
Mechanism of immune response to muscle-directed AAV gene transfer
肌肉定向 AAV 基因转移的免疫反应机制
- 批准号:
10717750 - 财政年份:2023
- 资助金额:
$ 26.58万 - 项目类别:
Strategies to attenuate the indirect alloimmune response in encapsulated pancreatic islet transplantation
减弱封装胰岛移植中间接同种免疫反应的策略
- 批准号:
10678425 - 财政年份:2023
- 资助金额:
$ 26.58万 - 项目类别: